Novel inhibitor N-cyclopropyl-4-((4-((4-(trifluoromethyl)phenyl)sulfonyl)piperazin-1-yl)methyl)benzamide attenuates RANKL-mediated osteoclast differentiation in vitro

Autor:	Marie Encarnacion, Alessandra, Pootheri, Nithin, Yao, Hongyuan, Chen, Zhihao, Lee, Sunwoo, Kim, Eunae, Lee, Tae-Hoon
Zdroj:	In Bioorganic & Medicinal Chemistry Letters 15 September 2024 110
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect